- Greenwashing

Cepham has developed SheVari4, a patented adaptogen derived from the traditional Ayurvedic herb Shatavari, targeting women’s hormonal balance, mood, and stress response. By isolating specific bioactive molecules like shatavarin IV, the company positions this ingredient as a scientifically validated solution for various life stages, from menstruation to menopause. The narrative emphasizes bridging the gap between ancestral wisdom and modern phytochemistry, promising standardized benefits for issues such as hot flashes, anxiety, and sleep disturbances. The company frames its development as a response to the under-researched landscape of women’s health ingredients, claiming their in-house studies provide the necessary scientific backing where previous knowledge was lacking. This marketing strategy leverages personal storytelling, specifically the founder’s dialogue with his mother, to enhance the product’s perceived authenticity and cultural respect. By highlighting this intergenerational connection, Cepham attempts to legitimize its commercial offering through emotional resonance and traditional endorsement. This case is relevant to greenwashing because it exemplifies the trend of wrapping conventional supplements in narratives of traditional heritage and scientific rigor to create an aura of natural legitimacy. While the product contains a real herbal ingredient, the extensive emphasis on emotional storytelling and the framing of basic phytochemical analysis as a groundbreaking solution to a "vast void" may distract consumers from evaluating the actual clinical efficacy. Such practices can blur the lines between genuine scientific innovation and marketing-driven claims that exploit consumer desires for holistic, traditionally rooted wellness without substantive proof.

Source:
Published on 2024-01-10

Minns declares native logging ‘has a future’ after landmark court case dismissed »

Related news